Hypertension, Vol 20, 38-45, Copyright © 1992 by American Heart Association
SM Haffner, E Ferrannini, HP Hazuda and MP Stern
Numerous studies have indicated that hypertensive subjects have an
atherogenic lipoprotein pattern, hyperinsulinemia, and impaired glucose
tolerance relative to normotensive individuals. These abnormalities could
be due to adverse effects of certain antihypertensive agents, to
pathophysiological concomitants of the hypertensive state itself, or to
both. In this report, we describe the cardiovascular risk factor profile of
1,440 subjects who were normotensive and were not taking any
antihypertensive medications when first examined and who subsequently
participated in the 8-year follow-up of the San Antonio Heart Study.
Hypertension developed in 130 subjects during the follow-up period. At
baseline these prehypertensive individuals had significantly higher levels
of blood pressure, fasting total and low density lipoprotein cholesterol,
triglyceride, glucose, and insulin, and 2-hour glucose than those who
remained free of hypertension. In addition, they had higher body mass
indexes, a less favorable body fat distribution, and lower levels of high
density lipoprotein cholesterol. In multiple linear regression analyses,
baseline levels of triglyceride and blood pressure remained significantly
higher and high density lipoprotein cholesterol remained significantly
lower in the subjects who later converted to hypertension than in those who
remained normotensive. Although baseline insulin levels were also higher in
the prehypertensive subjects, this difference was not statistically
significant. In nonobese subjects, however, those with high baseline
insulin concentrations had an increased incidence of hypertension compared
with those with low insulin concentrations. The present results suggest
that the cluster of atherogenic changes associated with hypertension
actually precede the development of the hypertensive state.
ARTICLES
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7873.
This article has been cited by other articles:
![]() |
J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3671 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrannini Metabolic Syndrome: A Solution in Search of a Problem J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 396 - 398. [Full Text] [PDF] |
||||
![]() |
S. R. Srinivasan, L. Myers, and G. S. Berenson Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study Hypertension, July 1, 2006; 48(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Zanolin, F. Tosi, G. Zoppini, R. Castello, G. Spiazzi, R. Dorizzi, M. Muggeo, and P. Moghetti Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome: Assessment by principal component analysis in young hyperandrogenic women Diabetes Care, February 1, 2006; 29(2): 372 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Sesso, J. E. Buring, M. J. Chown, P. M Ridker, and J. M. Gaziano A Prospective Study of Plasma Lipid Levels and Hypertension in Women Arch Intern Med, November 14, 2005; 165(20): 2420 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arnlov, M. J. Pencina, B.-H. Nam, J. B. Meigs, C. S. Fox, D. Levy, R. B. D'Agostino, and R. S. Vasan Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking: Variations With Baseline Age, Body Mass Index, and Blood Pressure Circulation, September 20, 2005; 112(12): 1719 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Greenlund, J. B. Croft, and G. A. Mensah Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000 Arch Intern Med, October 25, 2004; 164(19): 2113 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rennie, N McCarthy, S Yazdgerdi, M Marmot, and E Brunner Association of the metabolic syndrome with both vigorous and moderate physical activity Int. J. Epidemiol., August 1, 2003; 32(4): 600 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Burke, K. Williams, K.M. V. Narayan, C. Leibson, S. M. Haffner, and M. P. Stern A Population Perspective on Diabetes Prevention: Whom should we target for preventing weight gain? Diabetes Care, July 1, 2003; 26(7): 1999 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, and S. B. Heymsfield The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med, February 24, 2003; 163(4): 427 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance Hypertension, November 1, 2002; 40(5): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marso Optimizing the diabetic formulary: beyond aspirin and insulin J. Am. Coll. Cardiol., August 21, 2002; 40(4): 652 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Panza High-Normal Blood Pressure -- More "High" Than "Normal" N. Engl. J. Med., November 1, 2001; 345(18): 1337 - 1340. [Full Text] [PDF] |
||||
![]() |
H. Allayee, T. W.A. de Bruin, K. Michelle Dominguez, L. S.-C. Cheng, E. Ipp, R. M. Cantor, K. L. Krass, E. T.P. Keulen, B. E. Aouizerat, A. J. Lusis, et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p Hypertension, October 1, 2001; 38(4): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S.-C. Cheng, R. C. Davis, L. J. Raffel, A. H. Xiang, N. Wang, M. Quinones, P.-Z. Wen, E. Toscano, J. Diaz, S. Pressman, et al. Coincident Linkage of Fasting Plasma Insulin and Blood Pressure to Chromosome 7q in Hypertensive Hispanic Families Circulation, September 11, 2001; 104(11): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Burke, K. Williams, S. M. Haffner, C. G. Villalpando, and M. P. Stern Elevated Incidence of Type 2 Diabetes in San Antonio, Texas, Compared With That of Mexico City, Mexico Diabetes Care, September 1, 2001; 24(9): 1573 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Xiang, S. P. Azen, L. J. Raffel, S. Tan, L. S.-C. Cheng, J. Diaz, E. Toscano, P. C. Henderson, H. N. Hodis, W. A. Hsueh, et al. Evidence for Joint Genetic Control of Insulin Sensitivity and Systolic Blood Pressure in Hispanic Families With a Hypertensive Proband Circulation, January 2, 2001; 103(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Carretero and S. Oparil Essential Hypertension : Part I: Definition and Etiology Circulation, January 25, 2000; 101(3): 329 - 335. [Full Text] [PDF] |
||||
![]() |
J.-R. Kim, C. I. Kiefe, K. Liu, O. D. Williams, D. R. Jacobs Jr, and A. Oberman Heart Rate and Subsequent Blood Pressure in Young Adults : The CARDIA Study Hypertension, February 1, 1999; 33(2): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrannini, A. Natali, B. Capaldo, M. Lehtovirta, S. Jacob, and H Yki-Jarvinen Insulin Resistance, Hyperinsulinemia, and Blood Pressure : Role of Age and Obesity Hypertension, November 1, 1997; 30(5): 1144 - 1149. [Abstract] [Full Text] |
||||
![]() |
S. M. Haffner, H. Miettinen, S. P. Gaskill, and M. P. Stern Metabolic Precursors of Hypertension: The San Antonio Heart Study Arch Intern Med, September 23, 1996; 156(17): 1994 - 2001. [Abstract] [PDF] |
||||
![]() |
J. Valek, L. Valkova, Z. Vlasakova, and V. Topinka Increased Fibrinogen Levels in the Offspring of Hypertensive Men : Relation With Hyperinsulinemia and the Metabolic Syndrome Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2229 - 2233. [Abstract] [Full Text] |
||||
![]() |
B. Falkner, H. Kushner, T. Tulenko, A. E. Sumner, and J. B. Marsh Insulin Sensitivity, Lipids, and Blood Pressure in Young American Blacks Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1798 - 1804. [Abstract] [Full Text] |
||||
![]() |
M. Manttari, L. Tenkanen, V. Manninen, T. Alikoski, and M. H. Frick Antihypertensive Therapy in Dyslipidemic Men : Effects on Coronary Heart Disease Incidence and Total Mortality Hypertension, January 1, 1995; 25(1): 47 - 52. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |